Melvin D Livingston1, Tracey E Barnett1, Chris Delcher1, Alexander C Wagenaar1. 1. Melvin D. Livingston is with the Department of Biostatistics and Epidemiology, School of Public Health, University of North Texas Health Science Center, Fort Worth. Tracey E. Barnett is with the Department of Health Behavior and Health Systems, School of Public Health, University of North Texas Health Science Center. Chris Delcher is with the Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville. Alexander C. Wagenaar is with the Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA.
Abstract
OBJECTIVES: To examine the association between Colorado's legalization of recreational cannabis use and opioid-related deaths. METHODS: We used an interrupted time-series design (2000-2015) to compare changes in level and slope of monthly opioid-related deaths before and after Colorado stores began selling recreational cannabis. We also describe the percent change in opioid-related deaths by comparing the unadjusted model-smoothed number of deaths at the end of follow-up with the number of deaths just prior to legalization. RESULTS: Colorado's legalization of recreational cannabis sales and use resulted in a 0.7 deaths per month (b = -0.68; 95% confidence interval = -1.34, -0.03) reduction in opioid-related deaths. This reduction represents a reversal of the upward trend in opioid-related deaths in Colorado. CONCLUSIONS: Legalization of cannabis in Colorado was associated with short-term reductions in opioid-related deaths. As additional data become available, research should replicate these analyses in other states with legal recreational cannabis.
OBJECTIVES: To examine the association between Colorado's legalization of recreational cannabis use and opioid-related deaths. METHODS: We used an interrupted time-series design (2000-2015) to compare changes in level and slope of monthly opioid-related deaths before and after Colorado stores began selling recreational cannabis. We also describe the percent change in opioid-related deaths by comparing the unadjusted model-smoothed number of deaths at the end of follow-up with the number of deaths just prior to legalization. RESULTS: Colorado's legalization of recreational cannabis sales and use resulted in a 0.7 deaths per month (b = -0.68; 95% confidence interval = -1.34, -0.03) reduction in opioid-related deaths. This reduction represents a reversal of the upward trend in opioid-related deaths in Colorado. CONCLUSIONS: Legalization of cannabis in Colorado was associated with short-term reductions in opioid-related deaths. As additional data become available, research should replicate these analyses in other states with legal recreational cannabis.
Authors: Chris Delcher; Alexander C Wagenaar; Bruce A Goldberger; Robert L Cook; Mildred M Maldonado-Molina Journal: Drug Alcohol Depend Date: 2015-02-19 Impact factor: 4.492
Authors: Alyssa C Mooney; Eric Giannella; M Maria Glymour; Torsten B Neilands; Meghan D Morris; Jacqueline Tulsky; May Sudhinaraset Journal: Am J Public Health Date: 2018-06-21 Impact factor: 9.308
Authors: Julie Bobitt; Sara H Qualls; Melissa Schuchman; Robert Wickersham; Hillary D Lum; Kanika Arora; Gary Milavetz; Brian Kaskie Journal: Drugs Aging Date: 2019-07 Impact factor: 3.923
Authors: Natasha A Sokol; Cassandra A Okechukwu; Jarvis T Chen; S V Subramanian; Vaughan W Rees Journal: Am J Prev Med Date: 2018-09-24 Impact factor: 5.043
Authors: Hudson Reddon; Kora DeBeck; M Eugenia Socias; Stephanie Lake; Huiru Dong; Mohammad Karamouzian; Kanna Hayashi; Thomas Kerr; M-J Milloy Journal: Am J Public Health Date: 2020-08-20 Impact factor: 9.308